Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Industry News

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

June 01, 2023

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-3 Trial Of Repatha® (Evolocumab) In Statin-Intolerant Patients With High Cholesterol

February 04, 2016

News Industry News

Roxwood Medical Proceeds with Full US Launch of Its MicroCross™ Catheter after 500+ Patients Are Successfully Treated during Limited Release

December 15, 2015

News Industry News

Avinger Successfully Completes VISION IDE Trial for Pantheris(TM)

November 02, 2015

News Industry News

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

October 06, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Industry News

Cordis Corporation Expands Crossing Portfolio for the Treatment of Chronic Total Occlusions

June 08, 2015

News Industry News

Medtronic Initiates U.S. Launch of HawkOne(tm) Directional Atherectomy System for Treatment of Peripheral Arterial Disease

April 09, 2015

News Industry News

CorPath® Robotic-Assisted Peripheral Vascular Intervention Trial Enrolls First Patient

February 23, 2015

News Industry News

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

October 10, 2014

News Industry News

Medtronic Expands Availability of Market-Leading Aortic & Peripheral Solutions to U.S. Market

June 04, 2014

News Industry News

Medtronic Launches 'TOTAL Across' Crossing Catheter in Europe

February 12, 2014

News Industry News

Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study

April 13, 2012

News Industry News

Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries

February 07, 2012

News Industry News

Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent

June 15, 2011

News Industry News

Medtronic Advances Research on Peripheral Devices, Highlights Upcoming Presentations

May 16, 2011

News Industry News

Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions

February 14, 2011

Advertisement

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-3 Trial Of Repatha® (Evolocumab) In Statin-Intolerant Patients With High Cholesterol

Roxwood Medical Proceeds with Full US Launch of Its MicroCross™ Catheter after 500+ Patients Are Successfully Treated during Limited Release

Avinger Successfully Completes VISION IDE Trial for Pantheris(TM)

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

Cordis Corporation Expands Crossing Portfolio for the Treatment of Chronic Total Occlusions

Medtronic Initiates U.S. Launch of HawkOne(tm) Directional Atherectomy System for Treatment of Peripheral Arterial Disease

CorPath® Robotic-Assisted Peripheral Vascular Intervention Trial Enrolls First Patient

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

Medtronic Expands Availability of Market-Leading Aortic & Peripheral Solutions to U.S. Market

Medtronic Launches 'TOTAL Across' Crossing Catheter in Europe

Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study

Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries

Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent

Medtronic Advances Research on Peripheral Devices, Highlights Upcoming Presentations

Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content